0120 (0120) Fair Value & Analysis

Real Estate · Market cap HK$90.2M

0 0120 0120 · HK

PriceHK$0.0550

Fair ValueHK$0.1007

Upside+83.0%

Quality28/100

Evidence: Low Range HK$0.0814 – HK$0.1337

Fair value as of: Jul 1, 2026

From 1 valuation models · updated today

Share price −14.1% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.0480 – HK$0.1400 · fair‑value band HK$0.0814 – HK$0.1337 · the HK$0.0550 price screens below the HK$0.1007 fair value. As of Jul 1, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0120 (0120) currently trades at HK$0.0550, while our model-based Fair Value estimate is HK$0.1007 — implying the stock looks roughly 83.0% undervalued today. We read business quality at 28/100 (below-average quality), in the Real Estate sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

Trailing-twelve-month revenue stands at HK$32.8M. Revenue declined 69.2% year over year. It earns a return on equity of -84.7%. Net debt stands at HK$1.2B. Fundamentals as of Jul 1, 2026

Key figures & financial health

Revenue (TTM) HK$32.8M

Revenue growth (YoY) -69.2%

Return on equity -84.7%

Free cash flow −HK$211M FY2025

Operating margin -145%

EPS (TTM) HK$-0.0400

More key figures

EPS growth (YoY) +6,821%

Net debt HK$1.2B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 1, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0120 reported revenue of HK$33.8M in FY2025 versus HK$1.6B in FY2021, a compound −62.1%/yr. Reported net income was −HK$453M in FY2025.

Revenue −62.1%/yr

FY21 HK$1.6B

FY22 HK$1.0B

FY23 HK$62.0M

FY24 HK$381M

FY25 HK$33.8M

Net income

FY21 HK$33.6M

FY22 HK$4.0M

FY23 −HK$372M

FY24 −HK$453M

FY25 −HK$453M

Is 0120 fairly valued? → Check now

Similar stocks

6 more Real Estate - Diversified stocks, each showing price versus our Fair Value estimate (as of Jul 1, 2026).

Stock	Price	Fair Value	vs Fair Value
Mitsubishi Estate Co MITEY	$24.70	$13.49	-45%
Mitsui Fudosan Co MTSFF	$9.40	$10.25	+9%
Henderson Land Development Company HLDVF	$3.70	$2.19	-41%
Swiss Prime Site AG SPSN	CHF 129.50	CHF 40.79	-69%
Central Pattana Public Company CPNR	64.00 THB	84.32 THB	+32%
SM Prime Holdings SPHXF	$0.2801	$0.6700	+139%

Explore undervalued stocks

More undervalued Real Estate stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 0120 (0120) undervalued?

As of Jul 1, 2026, our model estimates a fair value of HK$0.1007 versus a price of HK$0.0550 — about +83% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 0120?

Our model-based fair value for 0120 is HK$0.1007 (as of Jul 1, 2026), built from audited fundamentals. The current price is HK$0.0550.

What is the quality score of 0120?

0120 has a Quality Score of 28/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 0120 (0120)?

0120 reported trailing-twelve-month revenue of about HK$32.8M (latest available figure, as of Jul 1, 2026).

What is the net profit margin of 0120?

The net profit margin of 0120 is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.